04.05.2023 - Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or MindMed ), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported its financial results for the .
Mind Medicine(NASDAQ:NASDAQ:MNMD) Q1 2022 Earnings Conference Call May16, 2022, 08:30AM ET Company Participants Rob Barrow - CEO Dan Karlin - Chief Medical Officer Miri Halperin Wernli -.
<p>Based in Vancouver, Canada, Mind Medicine (MNMD) is a clinical-stage biopharmaceutical company that is developing psychedelics-based products to treat brain-health .
/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), (DE: MMQ); the "Company"), a leading biotech company developing psychedelic-inspired.
Inside of a Legal Psilocybin Wellness Retreat
At Benzinga, we do what we say, and we say what we do. This hands-on mentality allowed me to take a week off to experience a legal psilocybin retreat in Jamaica.
The active ingredient in “magic mushrooms” is currently being researched by top-tier institutions for the treatment of severe mental health conditions such as major depression, addiction, and end-of-life distress.
Psilocybin can also be a great tool for wellbeing and human optimization. The wellness aspect of psilocybin treatment has recently opened the gates to psychedelic tourism, as a rapidly growing trend. But, however fast the psychedelics industry is moving forward, psilocybin continues to be illegal in most countries and jurisdictions.